Follow
Thomas F Patterson
Thomas F Patterson
Professor of Medicine, The University of Texas Health Science Center at San Antonio
Verified email at uthscsa.edu
Title
Cited by
Cited by
Year
Remdesivir for the treatment of Covid-19
JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ...
New England Journal of Medicine 383 (19), 1813-1826, 2020
59082020
Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national …
B De Pauw, TJ Walsh, JP Donnelly, DA Stevens, JE Edwards, T Calandra, ...
Clinical infectious diseases 46 (12), 1813-1821, 2008
55932008
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht, DW Denning, TF Patterson, JE Bennett, RE Greene, ...
New England Journal of Medicine 347 (6), 408-415, 2002
38322002
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America
TJ Walsh, EJ Anaissie, DW Denning, R Herbrecht, DP Kontoyiannis, ...
Clinical infectious diseases 46 (3), 327-360, 2008
35742008
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus
S Ascioglu, JH Rex, B De Pauw, JE Bennett, J Bille, F Crokaert, ...
Проблемы медицинской микологии 5 (1), 10-16, 2003
28842003
Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America
TF Patterson, GR Thompson III, DW Denning, JA Fishman, S Hadley, ...
Clinical infectious diseases 63 (4), e1-e60, 2016
27652016
Remdesivir for the treatment of Covid-19—preliminary report
JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ...
New England Journal of Medicine 383 (19), 1813-1836, 2020
25342020
Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group …
JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ...
Clinical Infectious Diseases 71 (6), 1367-1376, 2020
18632020
Baricitinib plus remdesivir for hospitalized adults with Covid-19
AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ...
New England Journal of Medicine 384 (9), 795-807, 2021
17572021
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection …
DP Kontoyiannis, KA Marr, BJ Park, BD Alexander, EJ Anaissie, TJ Walsh, ...
Clinical infectious diseases 50 (8), 1091-1100, 2010
16122010
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)
PG Pappas, BD Alexander, DR Andes, S Hadley, CA Kauffman, A Freifeld, ...
Clinical Infectious Diseases 50 (8), 1101-1111, 2010
15842010
Practice guidelines for diseases caused by Aspergillus
DA Stevens, VL Kan, MA Judson, VA Morrison, S Dummer, DW Denning, ...
Clinical Infectious Diseases, 696-709, 2000
11472000
Invasive aspergillosis disease spectrum, treatment practices, and outcomes
TF Patterson, WR Kirkpatrick, M White, JW Hiemenz, JR Wingard, ...
Medicine 79 (4), 250-260, 2000
10682000
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial
TJ Walsh, I Raad, TF Patterson, P Chandrasekar, GR Donowitz, R Graybill, ...
Clinical infectious diseases 44 (1), 2-12, 2007
8902007
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled …
JA Maertens, II Raad, KA Marr, TF Patterson, DP Kontoyiannis, ...
The Lancet 387 (10020), 760-769, 2016
8652016
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy
J Maertens, I Raad, G Petrikkos, M Boogaerts, D Selleslag, FB Petersen, ...
Clinical Infectious Diseases 39 (11), 1563-1571, 2004
7942004
Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign
RE Greene, HT Schlamm, JW Oestmann, P Stark, C Durand, O Lortholary, ...
Clinical Infectious Diseases 44 (3), 373-379, 2007
7402007
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
P Koehler, M Bassetti, A Chakrabarti, SCA Chen, AL Colombo, M Hoenigl, ...
The Lancet Infectious Diseases 21 (6), e149-e162, 2021
7332021
European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study …
B De Pauw, TJ Walsh, JP Donnelly, DA Stevens, JE Edwards, T Calandra, ...
Clin Infect Dis 46 (12), 1813-1821, 2008
7232008
Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated …
S Perea, JL López-Ribot, WR Kirkpatrick, RK McAtee, RA Santillán, ...
Antimicrobial agents and chemotherapy 45 (10), 2676-2684, 2001
6302001
The system can't perform the operation now. Try again later.
Articles 1–20